Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook
Prostate cancer is a prevalent cancer in elderly men, and immunotherapy has emerged as a promising treatment approach in recent years. The aim of immunotherapy is to stimulate the body’s immune system to target and destroy cancer cells. Cancer vaccines that are highly specific, safe, and capable of...
Saved in:
| Main Authors: | Wenhao Zhou, Xiaojun Lu, Feng Tian, Qianming Luo, Weihang Zhou, Siyuan Yang, Wenxuan Li, Yongjun Yang, Minfeng Shi, Tie Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/12/1384 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Update on Prostate Cancer Immunotherapy
by: Juliana E. Kim, et al.
Published: (2023-03-01) -
Immunome profiling in prostate cancer: a guide for clinicians
by: Luis San-Jose Manso, et al.
Published: (2024-11-01) -
Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells
by: Joyce M. van Dodewaard-de Jong, et al.
Published: (2016-04-01) -
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity
by: Zhen Xu, et al.
Published: (2024-12-01) -
Potential and development of cellular vesicle vaccines in cancer immunotherapy
by: Wenxi Zhao, et al.
Published: (2025-01-01)